Sectors
ELV
Elevance Health Inc.
394.13
1 x 393.50
1 x 394.06
bid
ask
+
0.69
0.17%
10:03 AM
timesize
| Ytd | 12.43% | |
| 1y | 39.90% |
392.34
day range
394.85
274.66
52 week range
426.79
| Open | 392.80 | Prev Close | 393.44 | Low | 392.34 | High | 394.85 | Mkt Cap | 85.33B |
| Vol | 112.75K | Avg Vol | 1.79M | EPS | 29.39 | P/E | 13.39 | Forward P/E | 15.87 |
| Beta | 0.67 | Short Ratio | 3.32 | Inst. Own | 93.39% | Dividend | 6.88 | Div Yield | 1.84 |
| Ex Div Date | 06-10 | Earning | 07-15 | 50-d Avg | 398.62 | 200-d Avg | 350.07 | 1yr Est | 440.81 |
| Income Statement | |||
| Total Revenue | 50.47B | ||
| Revenues (USD) | 50.47B | ||
| Cost of Revenue | 42.52B | ||
| Gross Profit | 7.96B | ||
| Operating Expenses | 5.66B | ||
| Selling, General and Administrative Expense | 5.55B | ||
| Operating Income | 2.30B | ||
| Interest Expense | 364.00M | ||
| Income Tax Expense | 483.00M | ||
| Net Income | 1.46B | ||
| Net Income Common Stock | 1.46B | ||
| Net Income Common Stock (USD) | 1.46B | ||
| Consolidated Income | 1.45B | ||
| Net Income to Non-Controlling Interests | -9.00M | ||
| Earnings per Basic Share | 6.74 | ||
| Earnings per Basic Share (USD) | 6.74 | ||
| Earnings per Diluted Share | 6.71 | ||
| Dividends per Basic Common Share | 1.72 | ||
| Earning Before Interest & Taxes (EBIT) | 2.31B | ||
| Earning Before Interest & Taxes (USD) | 2.31B | ||
| Weighted Average Shares | 217.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.23B | ||
| Cash and Equivalents (USD) | 10.23B | ||
| Investments | 39.67B | ||
| Investments Current | 27.28B | ||
| Investments Non-Current | 12.39B | ||
| Trade and Non-Trade Receivables | 23.39B | ||
| Current Assets | 67.18B | ||
| Property, Plant & Equipment Net | 4.64B | ||
| Total Assets | 126.44B | ||
| Debt Current | 375.00M | ||
| Total Debt | 31.04B | ||
| Current Liabilities | 44.25B | ||
| Debt Non-Current | 30.67B | ||
| Total Liabilities | 81.42B | ||
| Accumulated Retained Earnings (Deficit) | 36.67B | ||
| Accumulated Other Comprehensive Income | -711.00M | ||
| Shareholders Equity | 44.88B | ||
| Shareholders Equity (USD) | 44.88B | ||
| Assets Non-Current | 59.25B | ||
| Total Debt (USD) | 31.04B | ||
| Deferred Revenue | 1.64B | ||
| Goodwill and Intangible Assets | 39.32B | ||
| Liabilities Non-Current | 37.16B | ||
| Trade and Non-Trade Payables | 25.10B | ||
| Tax Liabilities | 2.21B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 366.00M | ||
| Net Cash Flow from Financing | -1.49B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 575.00M | ||
| Capital Expenditure | -287.00M | ||
| Issuance (Purchase) of Equity Shares | -208.00M | ||
| Issuance (Repayment) of Debt Securities | -753.00M | ||
| Payment of Dividends & Other Cash Distributions | -373.00M | ||
| Net Cash Flow from Investing | 159.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 276.00M | ||
| Net Cash Flow from Operations | 1.91B | ||
| Effect of Exchange Rate Changes on Cash | -3.00M | ||
| Share Based Compensation | 75.00M | ||